291 research outputs found
Entraves à participação social dos representantes dos trabalhadores no conselho municipal de saúde
A análise de etilenotiouréia em mamão evita resultados falso positivos de resíduos de etileno(bis)ditiocarbamatos.
O principal produto de degradação de etileno(bisditiocarbamatos) (EBDCs) é a etilenotiouréia (ETU), que teoricamente pode estar presente em qualquer cultura tratada com esses fungicidas. A formação endógena de CS2 na família das Caricaceas é um fato comprovado e tem conduzido à conclusão errônea da presença de resíduos de EBDCs. Portanto, é necessário estabelecer um procedimento confirmatório para confirmar a presença desses resíduos, sendo uma possibilidade a determinação dos resíduos do seu metabólito ETU. O objetivo deste trabalho foi determinar os resíduos de ETU e de EBDCs em frutos de mamoeiro que receberam tratamento em campo com o fungicida mancozeb
Resíduos de mancozebe e etu em mamão: efeito do tratamento hidrotérmico pós-colheita.
O mancozebe é um fungicida não sistêmico, e seus resíduos devem ser diferentes em frutos que recebam ou não o tratamento hidrotérmico, por sua remoção da superfície dos frutos. Por outro lado uma das preocupações quanto à sua toxicologia é a formação de um produto de transformação, favorecido pela temperatura, a etilenotiouréia (ETU). A ETU é estável em água e é rapidamente absorvida e metabolizada pelas plantas mas, não é estável quando exposta a matrizes de produtos agrícolas. Os seus resíduos são estabelecidos em 50 µg kg-1 (50ppb) pela União Européia. O objetivo deste trabalho foi avaliar o efeito do tratamento hidrotérmico nos resíduos de mancozebe e de ETU em mamão após aplicações sucessivas de mancozebe
Surgical exposure of the internal auditory canal through the retrosigmoid approach with semicircular canals anatomical preservation
Perisylvian white matter connectivity in the human right hemisphere
Background By using diffusion tensor magnetic resonance imaging (DTI) and subsequent tractography, a perisylvian language network in the human left hemisphere recently has been identified connecting Brocas's and Wernicke's areas directly (arcuate fasciculus) and indirectly by a pathway through the inferior parietal cortex. Results Applying DTI tractography in the present study, we found a similar three-way pathway in the right hemisphere of 12 healthy individuals: a direct connection between the superior temporal and lateral frontal cortex running in parallel with an indirect connection. The latter composed of a posterior segment connecting the superior temporal with the inferior parietal cortex and an anterior segment running from the inferior parietal to the lateral frontal cortex. Conclusion The present DTI findings suggest that the perisylvian inferior parietal, superior temporal, and lateral frontal corticies are tightly connected not only in the human left but also in the human right hemisphere
Produção de mudas clonais de eucalipto em espuma fenólica: crescimento inicial e mortalidade
Do antibiotic-impregnated shunts in hydrocephalus therapy reduce the risk of infection? An observational study in 258 patients
<p>Abstract</p> <p>Background</p> <p>Shunt infection in hydrocephalus patients is a severe, even life-threatening complication. Antibiotic-impregnated shunts (AIS) have been developed in an attempt to reduce rate of shunt infection. The study was performed to analyze if AIS can diminish the rate of shunt infection. The pathogenic nature of shunt infection in patients with AIS systems and those without antibiotic impregnated shunts (non-AIS) was compared.</p> <p>Methods</p> <p>Over a period of 24 months in the Department of Neurosurgery at University Hospital of Tübingen shunt surgery was performed in 258 patients. In 86 patients AIS systems were implanted. Shunt catheters were commercially impregnated with clindamycin and rifampicin. Analysis of the clinical data included sex, age, classification of hydrocephalus, shunt types and risk factors for shunt infection [age (< 1 year and > 80 years), prematurely born patients, external ventricular drainage, former shunt infection, former systemic infection, disturbance of consciousness, former radiation-/chemotherapy]. Infection rates and underlying bacterial pathogens of patients with AIS were compared to patients with implanted non-AIS systems (172 patients).</p> <p>Results</p> <p>AIS and non-AIS patients did not differ in sex, etiology of hydrocephalus and the shunt type. In the AIS group 72 out of 86 patients had at least one risk factor (83.7 %), compared to 126 patients in the non-AIS group (73.3 %). There was no significant difference between the two groups (p = 0.0629; Fisher's exact test). In patients with no risk factors, only one patient with non-AIS suffered from shunt infection. In patients with one or more risk factors the rate for shunt infection was 7.14 % in patients with non-AIS and 6.94 % in patients with AIS. Former shunt infection (p = 0.0124) was related to higher risk for shunt infection. The use of AIS had therefore no significant advantage (p = 0.8611; multiple logistic regression).</p> <p>Significantly related to a shunt infection was the number of shunt surgeries. 190 interventions in the AIS group (2.21 interventions per patient) and 408 in the non-AIS group (2.37 interventions per patient) had been performed (p = 0.3063; Wilcoxon). There was no shunt infection in the group of patients on whom only one shunt surgery was performed. In patients with at least two shunt surgeries the infection rate was 9%. The infection rate in AIS patients was 5/52 (9.6 %) and in the non-AIS 10/114 (8.77 %), (p = 1.0; Fisher's exact test). Staphylococcus epidermidis was the most frequent pathogen for shunt infection. Fourteen out of 15 infections occurred within the first 6 months of surgery. The most frequent pathogen for shunt infection was S. epidermidis. No toxic or allergic complications were seen using the AIS shunt systems. The presented data show a remarkably low infection rate of 5.8 % in the non-AIS group compared to other studies which demonstrated a significant decrease in the infection rate by AIS.</p> <p>Conclusion</p> <p>AIS did not significantly reduce shunt infection in hydrocephalus patients in the presented study. In the AIS group three patients suffered from shunt infections caused by skin ulceration or neurosurgical procedures with exposure of the cerebrospinal liquor after shunt implantation. AIS was not developed to prevent infection in such cases, therefore an advantage of AIS can not be excluded. In view of the presented data and the small number of reported studies a prospective randomized multicenter study is required.</p
- …